Extensive Disease Small Cell Lung Cancer clinical trials

Explore recruiting extensive disease small cell lung cancer clinical trials.

Recruiting extensive disease small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Extensive Disease Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IFCT-2203 TAXIO A phase II study assessing the efficacy of etoposide free chemotherapy plus durvalumab (MEDI4736) in first line extensive disease Small Cell Lung Cancer (SCLC)

France, Luxembourg

Therapeutic exploratory (Phase II) EU CTIS Study details

ETOP 23-22 RAISE: A single-arm phase II study of the addition of niraparib to anti-PD-L1 antibody maintenance in patients with SLFN11-positive, extensive-disease small cell lung cancer.

Spain, France, Italy, Romania, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II Multicenter, Open-Label, Single Arm Study to Determine the Efficacy, Safety and Tolerability of AZD2811 and Durvalumab Combination as Maintenance Therapy After Induction with Platinum-Based Chemotherapy Combined with Durvalumab, for the First-Line Treatment of Patients with Extensive Stage Small-Cell Lung Cancer

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Extensive Disease Small Cell Lung Cancer trials by city

Extensive Disease Small Cell Lung Cancer in Toronto Extensive Disease Small Cell Lung Cancer in Vancouver Extensive Disease Small Cell Lung Cancer in Montreal Extensive Disease Small Cell Lung Cancer in Calgary Extensive Disease Small Cell Lung Cancer in Edmonton Extensive Disease Small Cell Lung Cancer in Ottawa Extensive Disease Small Cell Lung Cancer in Winnipeg Extensive Disease Small Cell Lung Cancer in Quebec City Extensive Disease Small Cell Lung Cancer in Hamilton Extensive Disease Small Cell Lung Cancer in Kitchener Extensive Disease Small Cell Lung Cancer in London Extensive Disease Small Cell Lung Cancer in Halifax Extensive Disease Small Cell Lung Cancer in New York Extensive Disease Small Cell Lung Cancer in Los Angeles Extensive Disease Small Cell Lung Cancer in Chicago Extensive Disease Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease